Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Merck & Co., Inc. (MRK) News - StockMarketCap

Stocks›Merck & Co., Inc.☆

● At closeAs of Jul 2, 2026

Merck & Co., Inc.

MRK✓

HealthcareDrug Manufacturers - GeneralNYSE

$129.52+3.31%

$319.89BMarket cap

36.07xP/E ratio

5.21MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$129.52

$4.15 (+3.31%) · 24h

Key metrics

Market cap$319.89B+11.57%

Enterprise value$360.94B

Volume (24h)5.21M

P/E ratio (TTM)36.07x

P/S ratio (TTM)4.84x

Dividend yield2.62%

Shares outstanding2.47B

Trading range

Previous close$125.37

Day range$125.99 - $129.59

52-week range$76.66 - $130.29

Merck & Co., Inc. (MRK) operates in the Drug Manufacturers - General industry within the Healthcare sector, listed on NYSE.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Novartis AG+2.42%

Latest news